Difficulty: Medium
Average Score: 81%
Practice
Prophylactic and rescue administrations of synthetic and natural surfactants have the following advantages EXCEPT
Correct answer
D
Rationale
Rationale:
The correct answer is D) reduces bronco-pulmonary dysplasia (BPD) rates. Prophylactic and rescue administrations of synthetic and natural surfactants in neonates with respiratory distress syndrome have been shown to provide numerous benefits, including reducing adverse outcomes, reducing neonatal mortality, and decreasing the risk for pneumothorax. However, the evidence supporting a significant reduction in BPD rates with surfactant therapy is not as strong.
Reducing adverse outcomes, neonatal mortality, and pneumothorax are well-documented advantages of surfactant administration in premature infants with respiratory distress. These benefits are supported by numerous studies and are key reasons why surfactant therapy is a standard of care in neonatal intensive care units.
Educationally, understanding the benefits and limitations of surfactant therapy is crucial for pediatric nurses caring for neonates with respiratory distress syndrome. By recognizing the advantages and potential limitations of surfactant therapy, nurses can provide more informed and effective care to their patients. It is important to stay updated on the latest evidence-based practices to ensure the best outcomes for neonates in their care.
The correct answer is D) reduces bronco-pulmonary dysplasia (BPD) rates. Prophylactic and rescue administrations of synthetic and natural surfactants in neonates with respiratory distress syndrome have been shown to provide numerous benefits, including reducing adverse outcomes, reducing neonatal mortality, and decreasing the risk for pneumothorax. However, the evidence supporting a significant reduction in BPD rates with surfactant therapy is not as strong.
Reducing adverse outcomes, neonatal mortality, and pneumothorax are well-documented advantages of surfactant administration in premature infants with respiratory distress. These benefits are supported by numerous studies and are key reasons why surfactant therapy is a standard of care in neonatal intensive care units.
Educationally, understanding the benefits and limitations of surfactant therapy is crucial for pediatric nurses caring for neonates with respiratory distress syndrome. By recognizing the advantages and potential limitations of surfactant therapy, nurses can provide more informed and effective care to their patients. It is important to stay updated on the latest evidence-based practices to ensure the best outcomes for neonates in their care.